FDA Clears Marketing Approval for Device to Reduce Hair Loss during Chemotherapy – CancerConnect News : CancerConnect News

Breast patients have stated that hair loss (alopecia) reduces their quality of life while undergoing treatment, as they often feel that they appear to others as a “cancer patient”, requiring uncomfortable wigs and/or hats and scarves to cover a bald head.


The DigniCap is a type of cap that is placed on a patient’s head during chemotherapy treatment. A cool liquid is circulated through the cap, while a neoprene cover maintains insulation to keep the cool temperatures within the cap.


The cold temperatures constrict the blood vessels, reducing the amount of chemotherapy which causes the hair loss, from reaching the hair follicles. Furthermore, the cool temperatures reduce the division of the cells of the hair follicles. This is important as chemotherapy tends to kill cells that are rapidly dividing.


In the press release announcing the marketing clearance for the cooling cap, William Maisel, M.D., M.P.H, acting director of the Office of Device Evaluation in the FDA’s Center for Devices and Radiological Health stated, “We are pleased to see a product for breast cancer patients that can minimize chemotherapy-induced hair loss and contribute to the quality of life of these individuals. Managing the side effects of chemotherapy is a critical component to overall health and recovery.”


Certain types of chemotherapy are strongly associated with causing hair loss, whereupon hair may gradually start to fall out either all over or in section; it may become thin; or it may fall out entirely.


Wow this is a big step in allowing us cancer patients to feel more normal and not to stand out so obviously in our daily activities …  

Check Also

‘Suicide’ gene therapy kills prostate cancer cells – BBC News

Using a virus to carry the gene therapy into the tumour cells, the result is ...

Leave a Reply

Your email address will not be published. Required fields are marked *